Replies to post #87343 on NanoViricides Inc. (NNVC)

[Rawnoc]

How many times have we heard they have sufficient money to get through clincals (at least phase I and II) only to see another equity raise? If one believes the notion presented here that it is prudent for a company to ensure their coffers are well stocked, then why doesn't the company stop presenting "sufficient funding" as a positive, as it obviously needs additional money to "be prudent."

My point was that there have been numerous posts (one today as a matter of fact) claiming the SP would be $10 as soon as they begin clinicals, yet there are numerous examples of companies in phase I or further, with similar solid financial footing, that are trading at cheaper market caps. CTIX is one good example.

Even with the reverse split taken into account, why is NNVC so much different?

[I Need Help]

I agree with your post except where you state:

Current SPs are irrelevant.

Current share price is irrelevant to an investor if time is also irrelevant to an investor.

There are several opportunity costs associated with owning a stock. Two biggies are the time value of money, and the inability to own an alternative investment of equal value at present time. Investments are dynamic, and every day we win or lose against alternative investments we did not make, for the limitations imposed by the investment choices we do make.

Otherwise, your post contains many wonderful points.

I have no doubt you believe the current NNVC share price is irrelevant to you. I believe you are in this for the long haul with little reservation. You have done your DD and have come to some strong conclusions. Conclusions which I pretty much agree with.

Just want to strongly state that your view that current share price is irrelevant is a subjective opinion, and far from universal. Being the logical person you are, maybe in the future you should consider writing: Current SPs are irrelevant to me.